Rapport Therapeutics, Inc. earnings per share and revenue

RAPP earnings per share for the last quarter are -0.57 USD whereas the estimation was -0.64 USD which accounts for 10.99% surprise. Company revenue for the same period amounts to 0.00 USD despite the estimated figure of 0.00 USD. Estimated earnings per share for the next quarter are -0.76 USD, and revenue is expected to reach 0.00 USD. Also watch annual changes over time to get a bigger picture of RAPP earnings per share and revenue dynamics.